Dogecoin Cash Revenue Dips 13% YTD Amidst Stiff Competition

TL;DR

**DOGP is burning cash and facing an existential threat from competition, making it a high-risk bet despite cost cuts.**

AI Summary

Dogecoin Cash, Inc. (DOGP) reported a mixed financial performance for the period ended September 30, 2025. For the three months, revenue increased by 1% to $190,564, primarily due to a modest uptick in patient certifications through PrestoDoctor and state-market expansions. However, for the nine months, revenue decreased by 13% to $567,501, attributed to significant competition in the cannabis tele-medicine industry. The company's net loss for the three months improved by 19% to $(147,169) from $(181,847) in the prior year, while the nine-month net loss significantly widened to $(7,581,141) from $(854,454), largely due to a $7,079,850 impairment expense on digital currency. Operating expenses decreased by 11% for the three months and 17% for the nine months, reflecting cost-management efforts, including a 23% reduction in PrestoDoctor wages and salaries. The company ended the quarter with only $29,978 in cash, indicating insufficient liquidity, and reported an accumulated deficit of $84,305,776, raising going concern doubts. Management also identified material weaknesses in disclosure controls due to a small accounting staff.

Why It Matters

Dogecoin Cash's struggle with declining revenue and a massive digital currency impairment loss signals significant challenges for investors, raising red flags about its long-term viability in a competitive cannabis telemedicine market. The company's precarious liquidity position, with only $29,978 in cash and an accumulated deficit of $84,305,776, directly impacts its ability to fund operations and grow, potentially leading to further shareholder dilution if new capital is raised. For employees and customers of PrestoDoctor, the cost-cutting measures and intense competition could affect service quality and job security. The identified material weaknesses in disclosure controls also undermine investor confidence and regulatory compliance, highlighting governance issues in a sector already under scrutiny.

Risk Assessment

Risk Level: high — Dogecoin Cash, Inc. faces a high risk level due to its significant net loss of $(7,581,141) for the nine months ended September 30, 2025, primarily driven by a $7,079,850 impairment expense on digital currency. The company's cash on hand of $29,978 is insufficient to meet immediate operational needs, and it has an accumulated deficit of $84,305,776, raising substantial doubt about its ability to continue as a going concern. Furthermore, management identified material weaknesses in disclosure controls and procedures due to a small accounting staff, indicating internal control deficiencies.

Analyst Insight

Investors should exercise extreme caution and consider divesting from DOGP given the severe liquidity issues, substantial accumulated deficit, and significant impairment losses. The identified material weaknesses in internal controls add another layer of risk, suggesting potential governance and reporting deficiencies. New investors should avoid this stock until the company demonstrates a clear path to profitability, secures substantial new capital, and remediates its internal control weaknesses.

Financial Highlights

revenue

$190,564

total Assets

$2,062,501

total Debt

$2,128,846

net Income

$(147,169)

gross Margin

64%

cash Position

$29,978

revenue Growth

1%

Revenue Breakdown

Key Numbers

• $190,564 — Revenue (3 months) (Increased 1% from $189,121 in Q3 2024, driven by PrestoDoctor patient certifications.)
• $567,501 — Revenue (9 months) (Decreased 13% from $648,643 in the prior year, due to increased competition.)
• $(147,169) — Net Loss (3 months) (Improved 19% from $(181,847) in Q3 2024.)
• $(7,581,141) — Net Loss (9 months) (Significantly widened from $(854,454) in the prior year, largely due to digital currency impairment.)
• $7,079,850 — Digital Currency Impairment (A major non-operating expense contributing to the nine-month net loss.)
• $29,978 — Cash on Hand (Insufficient liquidity to meet immediate operational needs as of September 30, 2025.)
• $84,305,776 — Accumulated Deficit (Indicates significant historical losses and raises going concern doubts.)
• 1% — Q3 Revenue Growth (Modest growth for the three months ended September 30, 2025.)
• -13% — YTD Revenue Decline (Significant decline for the nine months ended September 30, 2025.)
• -23% — PrestoDoctor Wages & Salaries Decrease (Reflects cost-management efforts, reducing expenses by approximately $66,000.)

Key Players & Entities

• Dogecoin Cash, Inc. (company) — registrant of the 10-Q filing
• PrestoDoctor (company) — subsidiary driving patient certifications and revenue
• David Tobias (person) — Principal Executive Officer and Principal Financial Officer
• SEC (regulator) — Securities and Exchange Commission
• $190,564 (dollar_amount) — revenue for the three months ended September 30, 2025
• $567,501 (dollar_amount) — revenue for the nine months ended September 30, 2025
• $7,581,141 (dollar_amount) — net loss for the nine months ended September 30, 2025
• $7,079,850 (dollar_amount) — impairment expense on digital currency
• $29,978 (dollar_amount) — cash on hand as of September 30, 2025
• $84,305,776 (dollar_amount) — accumulated deficit as of September 30, 2025

FAQ

Risk Factors

• Insufficient Liquidity [high — financial]: The company ended the quarter with only $29,978 in cash, which is insufficient to meet immediate operational needs. This low cash position, coupled with an accumulated deficit of $84,305,776, raises significant going concern doubts.
• Significant Accumulated Deficit [high — financial]: The company has an accumulated deficit of $84,305,776 as of September 30, 2025. This indicates substantial historical losses and poses a risk to the company's long-term viability.
• Digital Currency Impairment [high — financial]: A substantial impairment expense of $7,079,850 on digital currency significantly widened the nine-month net loss. This highlights the volatility and risk associated with the company's digital asset holdings.
• Material Weaknesses in Disclosure Controls [medium — operational]: Management identified material weaknesses in disclosure controls due to a small accounting staff. This could lead to errors in financial reporting and impact investor confidence.
• Intense Industry Competition [medium — market]: The company faces significant competition in the cannabis telemedicine industry, which has contributed to a 13% decrease in revenue for the nine-month period. This competitive pressure may continue to impact revenue and profitability.
• Uncertainty in Digital Currency Regulations [medium — regulatory]: The company's significant investment in digital currency exposes it to risks associated with evolving and uncertain regulatory landscapes governing digital assets.

Industry Context

The cannabis telemedicine industry is experiencing significant competition, impacting revenue growth for companies like Dogecoin Cash, Inc. While state-market expansions and new referral arrangements offer opportunities, intense competition can suppress pricing and market share. The industry also faces evolving regulatory landscapes, particularly concerning digital assets if companies engage in such investments.

Regulatory Implications

The company's identification of material weaknesses in disclosure controls due to a small accounting staff could attract scrutiny from regulatory bodies like the SEC. Furthermore, any significant involvement with digital currencies may expose the company to evolving regulations in that sector.

What Investors Should Do

1. Monitor cash burn rate closely.
2. Assess the sustainability of revenue drivers.
3. Evaluate the impact of digital currency volatility.
4. Understand the plan to address material weaknesses.

Key Dates

• 2025-09-30: End of Q3 2025 — Reported $190,564 in revenue, a 1% increase year-over-year, but a net loss of $(147,169). Cash on hand was critically low at $29,978.
• 2025-09-30: Nine Months Ended Q3 2025 — Revenue decreased 13% to $567,501, and net loss widened significantly to $(7,581,141) due to a $7,079,850 digital currency impairment.

Glossary

Accumulated deficit

The total net losses of a company since its inception, minus any net profits. It represents the cumulative losses that have not been offset by profits. (Indicates significant historical losses for Dogecoin Cash, Inc., raising concerns about its long-term financial health and ability to continue as a going concern.)

Impairment expense

A charge taken when the carrying value of an asset on the balance sheet is reduced because it has lost value. This can be due to market conditions, obsolescence, or other factors. (A substantial $7,079,850 impairment expense on digital currency was a primary driver of the widened net loss for the nine-month period.)

Going concern

An accounting assumption that a business will continue to operate for the foreseeable future. If there are doubts about a company's ability to continue as a going concern, it must be disclosed. (The company's low cash balance and large accumulated deficit raise doubts about its ability to continue as a going concern.)

Material weakness

A deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. (Dogecoin Cash, Inc. identified material weaknesses in its disclosure controls due to a small accounting staff, impacting the reliability of its financial reporting.)

PrestoDoctor

A service or platform offered by Dogecoin Cash, Inc. that facilitates patient certifications, likely within the cannabis industry given the company's context. (Patient certifications through PrestoDoctor were cited as a primary driver for the modest revenue increase in the three-month period.)

Year-Over-Year Comparison

Compared to the prior year, Dogecoin Cash, Inc. saw a modest 1% revenue increase for the three months ended September 30, 2025, reaching $190,564, driven by patient certifications. However, the nine-month revenue declined 13% to $567,501 due to increased competition. The net loss for the quarter improved by 19% to $(147,169), but the nine-month net loss widened dramatically to $(7,581,141) primarily due to a $7,079,850 digital currency impairment. Operating expenses decreased, reflecting cost-saving measures, but the company's cash position has fallen to $29,978, and its accumulated deficit has grown to $84,305,776, intensifying going concern doubts.

Key Financial Figures

• $66,000 — es and salaries decreased approximately $66,000, or 23%, to $227,295 for the nine month
• $227,295 — eased approximately $66,000, or 23%, to $227,295 for the nine months ended September 30,
• $293,373 — ended September 30, 2025, compared with $293,373 for the nine months ended September 30,
• $36,658 — Cash used in operating activities was $36,658 in the nine months ended September 30,
• $29,978 — We ended the third quarter of 2025 with $29,978 in cash on hand. The accompanying cond
• $7,581,141 — of business. We incurred net losses of $7,581,141 and $854,454, respectively, for the nin
• $854,454 — e incurred net losses of $7,581,141 and $854,454, respectively, for the nine months ende
• $84,305,776 — 2024 and had an accumulated deficit of $84,305,776 as of September 30, 2025. The Company m

Filing Documents

• dogp-20250930_10q.htm (10-Q) — 774KB
• dogp_ex31z1.htm (EX-31.1) — 12KB
• dogp_ex31z2.htm (EX-31.2) — 12KB
• dogp_ex32z1.htm (EX-32.1) — 4KB
• dogp_ex32z2.htm (EX-32.2) — 5KB
• 0001096906-25-001794.txt ( ) — 3409KB
• dogp-20250930_cal.xml (EX-101.CAL) — 31KB
• dogp-20250930_def.xml (EX-101.DEF) — 114KB
• dogp-20250930_lab.xml (EX-101.LAB) — 206KB
• dogp-20250930_pre.xml (EX-101.PRE) — 183KB
• dogp-20250930.xsd (EX-101.SCH) — 41KB
• dogp-20250930_10q_htm.xml (XML) — 404KB

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. Attached after signature page.

Cybersecurity

Item 1C. Cybersecurity We recognize the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity, and availability of our data. We currently have security measures in place to protect our clients, customers, employees, and vendor information and prevent data loss and other security breaches. We only use third party software for accounting, billing and payroll that has robust compliance and is actively involved in continuous assessment of risks from cybersecurity threats, including prevention, mitigation, detection, and remediation of cybersecurity incidents. Our CEO is responsible for overseeing our business operations and is responsible for day-to-day assessment and confers weekly with subsidiary webmaster to understand any risks from cybersecurity threats, including the prevention, mitigation, detection, and remediation of cybersecurity incidents. As our core operations are virtual, it is routine to undertake activities to prevent, detect, and minimize the effects of cybersecurity incidents, maintain business continuity, contingency, and have recovery plans for use in the event of a cybersecurity incident by the administering of local and cloud based back up of files and emails. We currently do not carry a cyber liability insurance policy but are evaluating whether to acquire one to mitigate any financial impact of a cybersecurity breach.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Certain statements in this Report constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, among others, uncertainties relating to general economic and business conditions; industry trends; changes in demand for our products and services; uncertainties relating to customer plans and commitments and the timing of orders received from customers; announcements or changes in our pricing policies or that of our competitors; unanticipated delays in the development, market acceptance or installation of our products and services; changes in government regulations; availability of management and other key personnel; availability, terms, and deployment of capital; relationships with third-party equipment suppliers; and worldwide political stability and economic growth. The words "believe," "expect," "anticipate," "intend" and "plan" and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Results of Operations Three Months Ended September 30, 2025 compared with the Three Months Ended September 30, 2024 Three Months Ended A B A-B September 30, September 30, Change Change % 2025 2024 REVENUE $ 190,564 $ 189,121 $ 1,443 1 % Cost of revenues 68,615 70,249 (1,634) (2) % Cost of sales % of total sales 36 % 37 % (1) % (3) % Gross profit 121,949 118,872 3,077 3 % Gross profit % of sales 64 % 63 % EXPENSES Professional fees 70,309 114,456

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk. Not required.

Controls and Procedures

Item 4. Controls and Procedures. Disclosure Controls and Procedures Conclusions of Management Regarding Effectiveness of Disclosure Controls and Procedures At the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was carried out under the supervision and with the participation of the Company's management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operations of the Company's disclosure controls and procedures (as defined in Rule 13a – 15(e) and Rule 15d – 15(e) under the Exchange Act). Based on that evaluation, the CEO and the CFO have concluded that as of the end of the period covered by this report, the Company's disclosure controls and procedures were not effective as it was determined that there were material weaknesses affecting our disclosure controls and procedures. Management of the Company believes that these material weaknesses are due to the small size of the company's accounting staff. The small size of the Company's accounting staff may prevent adequate controls in the future, such as segregation of duties, due to the cost/benefit of remediation. To mitigate the current limited resources and limited employees, we rely heavily on direct management oversight of transactions, along with the use of external legal and accounting professionals. As the Company grows, management expects to increase the number of employees, which will enable us to implement adequate segregation of duties within the internal control framework. Changes in Internal Control over Financial Reporting There was no change in our internal control over financial reporting during the quarter ended September 30, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

– OTHER INFORMATION

PART II – OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings. We are not a party to any material legal proceedings, and, to the best of our knowledge, no such legal proceedings have been threatened against us.

Risk Factors

Item 1A. Risk Factors Not required.

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. None

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities. None.

Mine Safety Disclosures

Item 4. Mine Safety Disclosures. Not applicable.

Other Information

Item 5. Other Information. None.

Exhibits

Item 6. Exhibits. The following documents are included as exhibits to this report: (a) Exhibits Exhibit Number SEC Reference Number Title of Document Notes 3.1 3 Articles of Incorporation (1) 3.2 3 Bylaws (1) 31.1 31 Section 302 Certification of Principal Executive Officer 31.2 31 Section 302 Certification of Principal Financial Officer 32.1 32 Section 1350 Certification of Principal Executive Officer 32.2 32 Section 1350 Certification of Principal Financial Officer 101.INS XBRL Instance Document (2) 101.SCH XBRL Taxonomy Extension Schema (2) 101.CAL XBRL Taxonomy Extension Calculation Linkbase (2) 101.DEF XBRL Taxonomy Extension Definition Linkbase (2) 101.LAB XBRL Taxonomy Extension Label Linkbase (2) 101.PRE XBRL Taxonomy Extension Presentation Linkbase (2) (1) Incorporated by reference to Exhibits 3.01 and 3.02 of the Company's Registration Statement on Form 10 filed January 28, 2009. (2) XBRL information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and is not subject to liability under those sections, is not part of any registration statement or prospectus to which it relates and is not incorporated or deemed to be incorporated by reference into any registration statement, prospectus or other document.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dogecoin Cash, Inc. Date: November 13, 2025 By: /s/ David Tobias David Tobias Principal Executive Officer Principal Financial Officer DOGECOIN CASH, INC. Contents Page

FINANCIAL STATEMENTS - UNAUDITED – for the three and six months ended June 30, 2025 and 2024

FINANCIAL STATEMENTS - UNAUDITED – for the three and six months ended June 30, 2025 and 2024: Condensed consolidated balance sheets FS-2 Condensed consolidated statements of operations FS-3 Condensed consolidated statements of changes in stockholders' equity FS-4 Condensed consolidated statements of cash flows FS-5 Notes to condensed consolidated financial statements FS-6 through FS-12 DOGECOIN CASH, INC. CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED September 30, December 31, 2025 2024 ASSETS Current Assets Cash $ 29,978 $ 34,934 Investment in equity securities, at fair value 750,000 317,100 Total Current Assets 779,978 352,034 Advances to related parties, net of allowance for bad debts 1,250 76,305 Property and equipment, net 1,958 2,163 Intangible assets, net 3,504 4,203 Goodwill 1,275,811 1,275,811 Total Assets $ 2,062,501 $ 1,710,516 LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued expenses $ 166,163 $ 149,480 Accrued interest - related parties 38,671 30,005 Fair value of convertible component in convertible loans 174,387 174,490 Convertible notes payable 183,270 177,736 Notes payable to related parties 234,683 184,038 Total Current Liabilities 797,174 715,749 Long-term liabilities Stock payable 1,331,672 1,123,639 Total Liabilities 2,128,846 1,839,388 Commitments and contingencies (Notes 6 and 8) Stockholders' Deficit Preferred Stock $ 0.001 par value; 5,000,000 shares authorized; 4,652,675 and 4,500,000 shares issued and outstanding, respectively 4,653 4,500 Common stock $ 0.001 par value; 495,000,000 shares authorized; 160,109,031 and 143,903,923 shares issued and outstanding, respectively 160,108 143,904 Additional paid-in capital 82,337,934 82,229,325 Warrant Equity 18,702 - Accumulated deficit ( 84,305,776 ) ( 83,816,573 ) Total Cannabis Sativa, Inc. Stockholders'

View Full Filing

View this 10-Q filing on SEC EDGAR